Session Details

Improving compliance with low-dose acetylsalicylic acid (ASA) – New insights
28 Aug 12:45 - 13:30 Antithrombotic agents EBAC Accredited Educational Programme Ankara - Zone F
Chairpersons: Gilles MONTALESCOT (Paris, FR), Freek VERHEUGT (Amsterdam, NL)
Subtitle: EBAC Accredited Educational Programme organised by the Sahlgrenska Academy - Goteborg University / Course Director: Prof. K. Swedberg / Programme supported by an unrestricted educational grant from AstraZeneca

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
12:45990Welcome and introduction.Freek VERHEUGT (Amsterdam, NL), Gilles MONTALESCOT (Paris, FR)
12:55991Clinical importance of low-dose acetylsalicylic acid and the consequences of non-compliance.Harald DARIUS (Berlin, DE)
13:05992High-risk cardiovascular patients - Clinical implications of gastrointestinal risk.Freek VERHEUGT (Amsterdam, NL)
13:15993Reducing the gastrointestinal risks of antiplatelet therapy.James SCHEIMAN (Ann Arbor, US)
13:25994Discussion and concluding remarks.Freek VERHEUGT (Amsterdam, NL)

Who we are

What we do

How we work

More ESC